Neuro Mapper is a behavioral brain mapping platform for clinicians and researchers, offering cognitive and sensory paradigms for functional localization on iOS.
The App DNA
What makes this app unique?
The platform removes the friction of manual baseline data integration by recording patient accuracy metrics to inform subsequent mapping sessions.
For Clinicians and researchers conducting behavioral brain mapping and functional localization studies.
Key features
Cognitive and sensory paradigms assess language, learning, memory, executive functions, and vision.
Adjusts testing parameters based on patient ability levels and baseline performance metrics.
Records accuracy and behavioral metrics during initial testing to inform subsequent mapping sessions.
How much does it cost?
The platform operates as a free research tool provided by an academic institution with no consumer-facing monetization.
Velocity
Dormant developmentUX improvementsShow more...
Neuro Mapper has been inactive for 1,252 days, indicating a complete cessation of development. The project shows no signs of recent updates, feature additions, or maintenance. Given the lack of activity over the past three years, the app is classified as a zombie project.
Who built it?
The Medical College of Wisconsin
2 apps tracked · Medical
Steroid Taper Calculator TMUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Neuro Mapper
How's the Medical market?
Neuro Mapper holds a niche position in the Medical category, supported by a 5-star rating based on a single store review. The absence of recent updates over the last 1,253 days limits its competitive visibility against active clinical research tools.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Neuro Mapper
Where is it heading?
The market for clinical brain mapping tools is shifting toward cloud-integrated, frequently updated platforms. Neuro Mapper remains stable due to its academic backing, but the lack of development velocity leaves it vulnerable to more agile research tools that offer faster paradigm iteration.
- The 1,253-day update gap suggests the platform is in maintenance mode, which limits its ability to adapt to new clinical research standards.
- The research consortium model provides a stable, non-commercial user base that is less sensitive to the lack of frequent feature updates.
The SWOT
- Baseline data integration creates longitudinal patient tracking
- Academic research consortium provides B2B distribution
- Expand paradigms via the existing research consortium
Next best moves
Audit research consortium roadmap because the current 3-year development gap risks partner churn → maintain clinical relevance
The counter-intuitive read
The lack of commercial monetization is not a…
Read the full takeBottom line
Neuro Mapper provides specialized clinical utility, but the three-year development stagnation threatens its long-term adoption. Establishing a predictable update cadence would secure its position within the research consortium before academic partners migrate to more active alternatives.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated